Neuroimaging in assessment of risk of stroke in children with sickle cell disease

Advances in Medical Sciences

Volumn 55, Issue 2, 2010, Pages 115-129

  Arkuszewski, M ^a,b   Melhem, E ^a   Krejza, J ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

children; imaging; risk; sickle cell disease; stroke; transcranial Doppler

Indexed keywords

ARTICLE; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; HEALTH CARE COST; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RISK ASSESSMENT; SICKLE CELL ANEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

EID: 78650451206     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-010-0045-0     Document Type: Review

References (179)

1. Pavlakis SG, Kingsley PB, Bialer MG. Stroke in children: Genetic and metabolic issues. J Child Neurol. 2000 May;15(5):308-315.
2. Prohovnik I, Pavlakis SG, Piomelli S, Bello J, Mohr JP, Hilal S, De Vivo DC. Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology. 1989 Mar;39(3):344-348.
3. Lipowsky HH, Cram LE, Justice W, Eppihimer MJ. Effect of erythrocyte deformability on in vivo red cell transit time and hematocrit and their correlation with in vitro filterability. Microvasc Res. 1993 Jul;46(1):43-64.
4. Lipowsky HH. Microvascular rheology and hemodynamics. Microcirculation. 2005 Jan-Feb;12(1):5-15.
5. Zhao Y, Chien S, Skalak R, Lipowsky HH. Leukocyte rolling in rat mesentery venules: Distribution of adhesion bonds and the effects of cytoactive agents. Ann Biomed Eng. 2001 May;29(5):360-372.
6. Dong C, Cao J, Struble EJ, Lipowsky HH. Mechanics of leukocyte deformation and adhesion to endothelium in shear flow. Ann Biomed Eng. 1999 May-Jun;27(3):298-312. (Pubitemid 129647572)
7. Mulivor AW, Lipowsky HH. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol. 2004 May;286(5):H1672-1680.
8. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy. Microcirculation. 2004 Mar;11(2):129-151.
9. Kaul DK, Fabry ME, Nagel RL. The pathophysiology of vascular obstruction in the sickle syndromes. Blood Rev. 1996 Mar;10(1):29-44.
10. Herold S, Brozovic M, Gibbs J, Lammertsma AA, Leenders KL, Carr D, Fleming JS, Jones T. Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography. Stroke. 1986 Jul-Aug;17(4):692-698.
11. Boas DA, Jones SR, Devor A, Huppert TJ, Dale AM. A vascular anatomical network model of the spatiotemporal response to brain activation. Neuroimage. 2008 Apr 15;40(3):1116-1129.
12. Prohovnik I, Hurlet-Jensen A, Adams R, De Vivo D, Pavlakis SG. Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease. J Cereb Blood Flow Metab. 2009 Apr;29(4):803-810.
13. Serjeant GR. The emerging understanding of sickle cell disease. Br J Haematol. 2001 Jan;112(1):3-18.
14. Stuart MJ, Setty BN. Hemostatic alterations in sickle cell disease: Relationships to disease pathophysiology. Pediatr Pathol Mol Med. 2001 Jan-Feb;20(1):27-46.
15. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood. 1998 Jan 1;91(1):288-294.
16. Embury SH. The not-so-simple process of sickle cell vasoocclusion. Microcirculation. 2004 Mar;11(2):101-113.
17. Miller S, Sleeper L, Pegelow C, Enos L, Wang W, Weiner S, Wethers D, Smith J, Kinney T. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000 JAN 13;342(2):83-89.
18. Wethers DL. Sickle cell disease in childhood: Part II. Diagnosis and treatment of major complications and recent advances in treatment. Am Fam Physician. 2000 Sep 15;62(6):1309-1314.
19. Stevens MC, Maude GH, Beckford M, Grandison Y, Mason K, Taylor B, Serjeant BE, Higgs DR, Teal H, Weatherall DJ, et al. Alpha thalassemia and the hematology of homozygous sickle cell disease in childhood. Blood. 1986 Feb;67(2):411-414. (Pubitemid 16164657)
20. Scothorn D, Price C, Schwartz D, Terrill C, Buchanan G, Shurney W, Sarniak I, Fallon R, Chu J, Pegelow C, Wang W, Casella J, Resar L, Berman B, Adamkiewicz T, Hsu L, Ohene-Frempong K, Smith-Whitley K, Mahoney D, Scott J, Woods G, Watanabe M, Debaun M. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 2002 Mar;140(3):348-354.
21. Hulbert M, Scothorn D, Panepinto J, Scott J, Buchanan G, Sarnaik S, Fallon R, Chu J, Wang W, Casella J, Resar L, Berman B, Adamkiewicz T, Hsu L, Smith-Whitley K, Mahoney D, Woods G, Watanabe M, DeBaun M. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: A retrospective cohort study of 137 children with sickle cell anemia. J Pediatr. 2006 Nov;149(5):710-712.
22. Garcia JH, Anderson ML. Physiopathology of cerebral ischemia. Crit Rev Neurobiol. 1989;4(4):303-324.
23. Di Roio C, Jourdan C, Terrier A, Artru F. Sickle cell anemia and internal cerebral vein thrombosis. Ann Fr Anesth Reanim. 1997;16(8):967-969.
24. Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol. 2003 Feb;53(2):167-173.
25. Kirkham FJ, Prengler M, Hewes DK, Ganesan V. Risk factors for arterial ischemic stroke in children. J Child Neurol. 2000 May;15(5):299-307.
26. Earley C, Kittner S, Feeser B, Gardner J, Epstein A, Wozniak M, Wityk R, Stern B, Price T, Macko R, Johnson C, Sloan M, Buchholz D. Stroke in children and sickle-cell disease - Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998 Jul;51(1):169-176. (Pubitemid 28345379)
27. Melek I, Akgul F, Duman T, Yalcin F, Gali E. Neurological soft signs as the stroke risk in sickle cell disease. Tohoku J Exp Med. 2006 Jun;209(2):135-140.
28. Mercuri E, Faundez JC, Roberts I, Flora S, Bouza H, Cowan F, Pennock J, Bydder G, Dubowitz L. Neurological 'soft' signs may identify children with sickle cell disease who are at risk for stroke. Eur J Pediatr. 1995 Feb;154(2):150-156.
29. Prengler M, Pavlakis SG, Boyd S, Connelly A, Calamante F, Chong WK, Saunders D, Cox T, Bynevelt M, Lane R, Laverty A, Kirkham FJ. Sickle cell disease: Ischemia and seizures. Ann Neurol. 2005 Aug;58(2):290-302.
30. Huttenlocher PR, Moohr JW, Johns L, Brown FD. Cerebral blood flow in sickle cell cerebrovascular disease. Pediatrics. 1984 May;73(5):615-621.
31. Kirkham FJ, Calamante F, Bynevelt M, Gadian DG, Evans JP, Cox TC, Connelly A. Perfusion magnetic resonance abnormalities in patients with sickle cell disease. Ann Neurol. 2001 Apr;49(4):477-485.
32. Kirkham F, Hewes D, Prengler M, Wade A, Lane R, Evans J. Nocturnal hypoxaemia and centralnervous- system events in sickle-cell disease. Lancet. 2001 May;357(9269):1656-1659.
33. Vichinsky E, Neumayr L, Earles A, Williams R, Lennette E, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci E. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000 Jun;342(25):1855-1865. (Pubitemid 30419049)
34. Lee KH, McKie VC, Sekul EA, Adams RJ, Nichols FT. Unusual encephalopathy after acute chest syndrome in sickle cell disease: Acute necrotizing encephalitis. J Pediatr Hematol Oncol. 2002 Oct;24(7):585-588.
35. Wierenga K, Serjeant B, Serjeant G. Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease. J Pediatr. 2001 Sep;139(3):438-442. (Pubitemid 32889523)
36. Strouse J, Hulbert M, DeBaun M, Jordan L, Casella J. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics. 2006 Nov;118(5):1916-1924.
37. Coley S, Porter D, Calamante F, Chong W, Connelly A. Quantitative MR diffusion mapping and cyclosporineinduced neurotoxicity. AJNR Am J Neuroradiol. 1999 Sep;20(8):1507-1510.
38. Horton D, Ferriero D, Mentzer W. Nontraumatic fat embolism syndrome in sickle cell anemia. Pediatr Neurol. 1995 Jan;12(1):77-80.
39. Gadian D, Calamante F, Kirkham F, Bynevelt M, Johnson C, Porter D, Chong W, Prengler M, Connelly A. Diffusion and perfusion magnetic resonance imaging in childhood stroke. J Child Neurol. 2000 May;15(5):279-283.
40. Powars D, Adams R, Nichols F, Milner P, Charache S, Sarnaik S. Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia. J Assoc Acad Minor Phys. 1990;1(3):79-82.
41. Sebire G, Tabarki B, Saunders DE, Leroy I, Liesner R, Saint-Martin C, Husson B, Williams AN, Wade A, Kirkham FJ. Cerebral venous sinus thrombosis in children: Risk factors, presentation, diagnosis and outcome. Brain. 2005 Mar;128(Pt 3):477-489.
42. Balkaran B, Char G, Morris J, Thomas P, Serjeant B, Serjeant G. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr. 1992 Mar;120(3):360-366.
43. Pegelow C, Macklin E, Moser F, Wang W, Bello J, Miller S, Vichinsky E, DeBaun M, Guarini L, Zimmerman R, Younkin D, Gallagher D, Kinney T. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002 Apr;99(8):3014-3018.
44. Aluoch J, Jacobs P. Sickle-cell disease in sub- Saharan Africa-past, present and future status. S Afr Med J. 1996 Aug;86(8):982-983.
45. Al-Riyami A, Ebrahim G. Genetic Blood Disorders Survey in the Sultanate of Oman. J Trop Pediatr. 2003 Jul;49 Suppl 1(i1-20).
46. De D. Sickle cell anaemia 1: Background, causes and incidence in the UK. Br J Nurs. 2005 Apr 28-May 11;14(8):447-450.
47. Balgir R. Genetic epidemiology of the three predominant abnormal hemoglobins in India. J Assoc Physicians India. 1996 Jan;44(1):25-28.
48. Fattoum S. [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data]. Tunis Med. 2006 Nov;84(11):687-696.
49. Hamdallah M, Bhatia A. Prevalence of sickle-cell trait in USA adolescents of Central American origin. Lancet. 1995 Sep;346(8976):707-708.
50. Kamble M, Chatruvedi P. Epidemiology of sickle cell disease in a rural hospital of central India. Indian Pediatr. 2000 Apr;37(4):391-396.
51. Williams T, Mwangi T, Wambua S, Alexander N, Kortok M, Snow R, Marsh K. Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis. 2005 Jul;192(1):178-186.
52. Al-Qurashi MM, El-Mouzan MI, Al-Herbish AS, Al-Salloum AA, Al-Omar AA. The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey. Saudi Med J. 2008 Oct;29(10):1480-1483.
53. el-Hazmi M, Warsy A. Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia. East Mediterr Health J. 1999 Nov;5(6):1147-1153.
54. Al-Awamy BH. Thalassemia syndromes in Saudi Arabia. Meta-analysis of local studies. Saudi Med J. 2000 Jan;21(1):8-17.
55. Petrakis N, Wiesenfeld S, Sams B, Collen M, Cutler J, Siegelaub A. Prevalence of sickle-cell trait and glucose- 6-phosphate dehydrogenase deficiency. N Engl J Med. 1970 Apr;282(14):767-770.
56. Scott R. Sickle-cell anemia-high prevalence and low priority. N Engl J Med. 1970 Jan;282(3):164-165.
57. Boyle EJ, Thompson C, Tyroler H. Prevalence of the sickle cell trait in adults of Charleston Charleston County, SC. An epidemiological study. Arch Environ Health. 1968 Dec;17(6):891-898.
58. Nietert P, Silverstein M, Abboud M. Sickle cell anaemia: Epidemiology and cost of illness. Pharmacoeconomics. 2002;20(6):357-366.
59. Hicks E, Miller G, Horton R. Prevalence of sickle cell trait and HbC-trait in Blacks from low socioeconomic conditions. Am J Public Health. 1978 Nov;68(11):1135-1137.
60. Ashley-Koch A, Yang Q, Olney R. Sickle hemoglobin (HbS) allele and sickle cell disease: A HuGE review. Am J Epidemiol. 2000 May;151(9):839-845.
61. Learning About Sickle Cell Disease. [Internet] National Human Genome Research Institute. 2010. Last Updated: July 7, 2010. [cited 2010 July 30]; Available from: Www.genome.gov/10001219.
62. Das L. Prevalence and association of sickle-cell haemoglobin and P. falciparum infection among tribals in Koraput District, Orissa State. Indian J Malariol. 2000 Mar- Jun;37(1-2):34-38.
63. Rodriguez-Ojea Menendez A, Garcia de la Osa M. [Malaria and sickle-cell anemia. A correlation of the clinical and epidemiological aspects]. Rev Cubana Med Trop. 1992;44(1):62-65.
64. deVeber G, Roach ES, Riela AR, Wiznitzer M. Stroke in children: Recognition, treatment, and future directions. Semin Pediatr Neurol. 2000 Dec;7(4):309-317.
65. Powars D, Wilson B, Imbus C, Pegelow C, Allen J. The natural history of stroke in sickle cell disease. Am J Med. 1978 Sep;65(3):461-471.
66. Dobson S, Holden K, Nietert P, Cure J, Laver J, Disco D, Abboud M. Moyamoya syndrome in childhood sickle cell disease: A predictive factor for recurrent cerebrovascular events. Blood. 2002 May;99(9):3144-3150.
67. Diggs LW, Brookoff D. Multiple cerebral aneurysms in patients with sickle cell disease. South Med J. 1993 Apr;86(4):377-379.
68. Royal JE, Seeler RA. Hypertension, convulsions, and cerebral haemorrhage in sickle-cell anaemia patients after blood-transfusions. Lancet. 1978 Dec 2;2(8101):1207.
69. Stockman J, Nigro M, Mishkin M, Oski F. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med. 1972 Oct;287(17):846-849.
70. Henderson J, Noetzel M, McKinstry R, White D, Armstrong M, DeBaun M. Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood. 2003 Jan;101(2):415-419.
71. Jeffries BF, Lipper MH, Kishore PR. Major intracerebral arterial involvement in sickle cell disease. Surg Neurol. 1980 Oct;14(4):291-295.
72. Charache S, Terrin M, Moore R, Dover G, Barton F, Eckert S, McMahon R, Bonds D. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995 May;332(20):1317-1322.
73. Hankins JS, Ware RE, Rogers ZR, Wynn LW, Lane PA, Scott JP, Wang WC. Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extension study. Blood. 2005 Oct 1;106(7):2269-2275.
74. Gulbis B, Haberman D, Dufour D, Christophe C, Vermylen C, Kagambega F, Corazza F, Devalck C, Dresse M, Hunninck K, Klein A, Le P, Loop M, Maes P, Philippet P, Sariban E, Van Geet C, Ferster A. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: The Belgian experience. Blood. 2005 Apr;105(7):2685-2690.
75. Moser F, Miller S, Bello J, Pegelow C, Zimmerman R, Wang W, Ohene-Frempong K, Schwartz A, Vichinsky E, Gallagher D, Kinney T. The spectrum of brain MR abnormalities in sickle-cell disease: A report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol. 1996 May;17(5):965-972.
76. Steen R, Emudianughe T, Hankins G, Wynn L, Wang W, Xiong X, Helton K. Brain imaging findings in pediatric patients with sickle cell disease. Radiology. 2003 Jul;228(1):216-225.
77. Kinney T, Sleeper L, Wang W, Zimmerman R, Pegelow C, Ohene-Frempong K, Wethers D, Bello J, Vichinsky E, Moser F, Gallagher D, DeBaun M, Platt O, Miller S. Silent cerebral infarcts in sickle cell anemia: A risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics. 1999 Mar;103(3):640-645.
78. Bernaudin F, Verlhac S, Freard F, Roudot-Thoraval F, Benkerrou M, Thuret I, Mardini R, Vannier JP, Ploix E, Romero M, Casse-Perrot C, Helly M, Gillard E, Sebag G, Kchouk H, Pracros JP, Finck B, Dacher JN, Ickowicz V, Raybaud C, Poncet M, Lesprit E, Reinert PH, Brugieres P. Multicenter prospective study of children with sickle cell disease: Radiographic and psychometric correlation. J Child Neurol. 2000 May;15(5):333-343.
79. Miller S, Macklin E, Pegelow C, Kinney T, Sleeper L, Bello J, DeWitt L, Gallagher D, Guarini L, Moser F, Ohene- Frempong K, Sanchez N, Vichinsky E, Wang W, Wethers D, Younkin D, Zimmerman R, DeBaun M. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: A report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001 Sep;139(3):385-390.
80. Baldeweg T, Hogan A, Saunders D, Telfer P, Gadian D, Vargha-Khadem F, Kirkham F. Detecting white matter injury in sickle cell disease using voxel-based morphometry. Ann Neurol. 2006 Apr;59(4):662-672.
81. DeBaun M, Schatz J, Siegel M, Koby M, Craft S, Resar L, Chu J, Launius G, Dadash-Zadeh M, Lee R, Noetzel M. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology. 1998 Jun;50(6):1678-1682.
82. Watkins K, Hewes D, Connelly A, Kendall B, Kingsley D, Evans J, Gadian D, Vargha-Khadem F, Kirkham F. Cognitive deficits associated with frontal-lobe infarction in children with sickle cell disease. Dev Med Child Neurol. 1998 Aug;40(8):536-543.
83. Hogan A, Kirkham F, Prengler M, Telfer P, Lane R, Vargha-Khadem F, Haan M. An exploratory study of physiological correlates of neurodevelopmental delay in infants with sickle cell anaemia. Br J Haematol. 2006 Jan;132(1):99-107.
84. Wang W, Enos L, Gallagher D, Thompson R, Guarini L, Vichinsky E, Wright E, Zimmerman R, Armstrong F. Neuropsychologic performance in school-aged children with sickle cell disease: A report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001 Sep;139(3):391-397. (Pubitemid 32889516)
85. Schatz J, Buzan R. Decreased corpus callosum size in sickle cell disease: Relationship with cerebral infarcts and cognitive functioning. J Int Neuropsychol Soc. 2006 Jan;12(1):24-33.
86. Kirkham F, Lerner N, Noetzel M, DeBaun M, Datta A, Rees D, Adams R. Trials in sickle cell disease. Pediatr Neurol. 2006 Jun;34(6):450-458.
87. Davis H, Moore RJ, Gergen P. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep. 1997 Jan-Feb;112(1):40-43. (Pubitemid 27053113)
88. Kauf TL, Coates TD, Liu HZ, Mody-Patel N, Hartzema AG. The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009 Jun;84(6):323-327.
89. Hassell KL. Population Estimates of Sickle Cell Disease in the US. Am J Prev Med. 2010 Apr;38(4):S512-S521.
90. Adams R, McKie V, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols F, Bonds D, Brambilla D. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul;339(1):5-11.
91. Wayne A, Schoenike S, Pegelow C. Financial analysis of chronic transfusion for stroke prevention in sickle cell disease. Blood. 2000 Oct;96(7):2369-2372.
92. Bernaudin F, Verlhac S, Coic L, Lesprit E, Brugieres P, Reinert P. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr Radiol. 2005 Mar;35(3):242-248.
93. Switzer J, Hess D, Nichols F, Adams R. Pathophysiology and treatment of stroke in sickle-cell disease: Present and future. Lancet Neurol. 2006 Jun;5(6):501-512.
94. Kirkham F. Therapy insight: Stroke risk and its management in patients with sickle cell disease. Nat Clin Pract Neurol. 2007 May;3(5):264-278.
95. Paediatric Stroke Working Group. Stroke in childhood: Clinical guidelines for diagnosis, management and rehabilitation. [Internet] Clinical Effectiveness and Evaluation Unit, Royal College of Physicians. 2004. Online: November 2004. [cited 2010 Aug 3]; Available from: Http:// www.rcplondon.ac.uk/pubs/books/ childstroke/childstroke-guidelines.pdf.
96. Winrow N, Melhem E. Sickle cell disease and stroke in a pediatric population. Evidence-based diagnostic evaluation. Neuroimaging Clin N Am. 2003 May;13(2):185-196.
97. Lev MH, Farkas J, Gemmete JJ, Hossain ST, Hunter GJ, Koroshetz WJ, Gonzalez RG. Acute stroke: Improved nonenhanced CT detection-benefits of soft-copy interpretation by using variable window width and center level settings. Radiology. 1999 Oct;213(1):150-155.
98. Lin K, Rapalino O, Law M, Babb JS, Siller KA, Pramanik BK. Accuracy of the Alberta Stroke Program Early CT Score during the first 3 hours of middle cerebral artery stroke: Comparison of noncontrast CT, CT angiography source images, and CT perfusion. AJNR Am J Neuroradiol. 2008 May;29(5):931-936.
99. Katz DA, Marks MP, Napel SA, Bracci PM, Roberts SL. Circle of Willis: Evaluation with spiral CT angiography, MR angiography, and conventional angiography. Radiology. 1995 May;195(2):445-449.
100. Bash S, Villablanca JP, Jahan R, Duckwiler G, Tillis M, Kidwell C, Saver J, Sayre J. Intracranial vascular stenosis and occlusive disease: Evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol. 2005 May;26(5):1012-1021.
101. Beyer J, Platt A, Kinney T, Treadwell M. Practice guidelines for the assessment of children with sickle cell pain. J Soc Pediatr Nurs. 1999 Apr-Jun;4(2):61-73.
102. Pavlakis S, Bello J, Prohovnik I, Sutton M, Ince C, Mohr J, Piomelli S, Hilal S, De Vivo D. Brain infarction in sickle cell anemia: Magnetic resonance imaging correlates. Ann Neurol. 1988 Feb;23(2):125-130.
103. DeBaun M, Glauser T, Siegel M, Borders J, Lee B. Noninvasive central nervous system imaging in sickle cell anemia. A preliminary study comparing transcranial Doppler with magnetic resonance angiography. J Pediatr Hematol Oncol. 1995 Feb;17(1):29-33.
104. Kidwell C, Chalela J, Saver J, Starkman S, Hill M, Demchuk A, Butman J, Patronas N, Alger J, Latour L, Luby M, Baird A, Leary M, Tremwel M, Ovbiagele B, Fredieu A, Suzuki S, Villablanca J, Davis S, Dunn B, Todd J, Ezzeddine M, Haymore J, Lynch J, Davis L, Warach S. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA. 2004 Oct;292(15):1823-1830.
105. Fiebach J, Schellinger P, Gass A, Kucinski T, Siebler M, Villringer A, Olkers P, Hirsch J, Heiland S, Wilde P, Jansen O, Rother J, Hacke W, Sartor K. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: A multicenter study on the validity of stroke imaging. Stroke. 2004 Feb;35(2):502-506.
106. Marks MP, de Crespigny A, Lentz D, Enzmann DR, Albers GW, Moseley ME. Acute and chronic stroke: Navigated spin-echo diffusion-weighted MR imaging. Radiology. 1996 May;199(2):403-408.
107. Gonzalez RG, Schaefer PW, Buonanno FS, Schwamm LH, Budzik RF, Rordorf G, Wang B, Sorensen AG, Koroshetz WJ. Diffusion-weighted MR imaging: Diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology. 1999 Jan;210(1):155-162.
108. Lovblad KO, Laubach HJ, Baird AE, Curtin F, Schlaug G, Edelman RR, Warach S. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR Am J Neuroradiol. 1998 Jun-Jul;19(6):1061-1066.
109. Mullins M, Schaefer P, Sorensen A, Halpern E, Ay H, He J, Koroshetz W, Gonzalez R. CT and conventional and diffusion-weighted MR imaging in acute stroke: Study in 691 patients at presentation to the emergency department. Radiology. 2002 Aug;224(2):353-360.
110. Lansberg M, Albers G, Beaulieu C, Marks M. Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology. 2000 Apr;54(8):1557-1561.
111. Lansberg M, Norbash A, Marks M, Tong D, Moseley M, Albers G. Advantages of adding diffusion-weighted magnetic resonance imaging to conventional magnetic resonance imaging for evaluating acute stroke. Arch Neurol. 2000 Sep;57(9):1311-1316.
112. Rovira A, Grive E, Alvarez-Sabin J. Distribution territories and causative mechanisms of ischemic stroke. Eur Radiol. 2005 Mar;15(3):416-426.
113. Kandeel A, Zimmerman R, Ohene-Frempong K. Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: Clinical significance and reliability. Neuroradiology. 1996 Jul;38(5):409-416.
114. de Bruijn SF, Stam J. Randomized, placebocontrolled trial of anticoagulant treatment with low-molecularweight heparin for cerebral sinus thrombosis. Stroke. 1999 Mar;30(3):484-488.
115. Mokri B, Sundt TM, Jr., Houser OW, Piepgras DG. Spontaneous dissection of the cervical internal carotid artery. Ann Neurol. 1986 Feb;19(2):126-138.
116. Gillams A, McMahon L, Weinberg G, Carter A. MRA of the intracranial circulation in asymptomatic patients with sickle cell disease. Pediatr Radiol. 1998 May;28(5):283-287.
117. Korogi Y, Takahashi M, Nakagawa T, Mabuchi N, Watabe T, Shiokawa Y, Shiga H, O'Uchi T, Miki H, Horikawa Y, Fujiwara S, Furuse M. Intracranial vascular stenosis and occlusion: MR angiographic findings. AJNR Am J Neuroradiol. 1997 Jan;18(1):135-143.
118. Kielpinska K, Walecki J, Giedrojc J, Turowska A, Kordecki K. Changes in the fibrinolytic system during angiography with ionic and with nonionic contrast media. Acad Radiol. 2002 Mar;9(3):283-289.
119. Srinivasan A, Goyal M, Al Azri F, Lum C. State-ofthe- art imaging of acute stroke. Radiographics. 2006 Oct;26 Suppl 1(S75-95.
120. Adams R, Nichols F, Figueroa R, McKie V, Lott T. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke. 1992 Aug;23(8):1073-1077.
121. Dawkins A, Evans A, Wattam J, Romanowski C, Connolly D, Hodgson T, Coley S. Complications of cerebral angiography: A prospective analysis of 2,924 consecutive procedures. Neuroradiology. 2007 Sep;49(9):753-759.
122. Rao K, Lee M. Risks associated with angiography in patients with sickle cell disease. Radiology. 1983 May;147(2):600-601.
123. Coley S, Wild J, Wilkinson I, Griffiths P. Neurovascular MRI with dynamic contrast-enhanced subtraction angiography. Neuroradiology. 2003 Dec;45(12):843-850.
124. Qureshi N, Lubin B, Walters M. The prevention and management of stroke in sickle cell anaemia. Expert Opin Biol Ther. 2006 Nov;6(11):1087-1098.
125. Verlhac S, Bernaudin F, Tortrat D, Brugieres P, Mage K, Gaston A, Reinert P. Detection of cerebrovascular disease in patients with sickle cell disease using transcranial Doppler sonography: Correlation with MRI, MRA and conventional angiography. Pediatr Radiol. 1995 Nov;25 Suppl 1(S14-19.
126. Chooi W, Woodhouse N, Coley S, Griffiths P. Pediatric head and neck lesions: Assessment of vascularity by MR digital subtraction angiography. AJNR Am J Neuroradiol. 2004 Aug;25(7):1251-1255.
127. Reed W, Jagust W, Al-Mateen M, Vichinsky E. Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. Am J Hematol. 1999 Apr;60(4):268-272.
128. Powars D, Conti P, Wong W, Groncy P, Hyman C, Smith E, Ewing N, Keenan R, Zee C, Harold Y, Hiti A, Teng E, Chan L. Cerebral vasculopathy in sickle cell anemia: Diagnostic contribution of positron emission tomography. Blood. 1999 Jan;93(1):71-79.
129. Rodgers GP, Clark CM, Larson SM, Rapoport SI, Nienhuis AW, Schechter AN. Brain glucose metabolism in neurologically normal patients with sickle cell disease. Regional alterations. Arch Neurol. 1988 Jan;45(1):78-82.
130. Adams R, Nichols F, McKie V, McKie K, Milner P, Gammal T. Cerebral infarction in sickle cell anemia: Mechanism based on CT and MRI. Neurology. 1988 Jul;38(7):1012-1017.
131. Brambilla D, Miller S, Adams R. Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell disease. Pediatr Blood Cancer. 2007 Sep;49(3):318-322.
132. Seibert J, Miller S, Kirby R, Becton D, James C, Glasier C, Wilson A, Kinder D, Berry D. Cerebrovascular disease in symptomatic and asymptomatic patients with sickle cell anemia: Screening with duplex transcranial Doppler US- correlation with MR imaging and MR angiography. Radiology. 1993 Nov;189(2):457-466.
133. Adams R, Brambilla D, Granger S, Gallagher D, Vichinsky E, Abboud M, Pegelow C, Woods G, Rohde E, Nichols F, Jones A, Luden J, Bowman L, Hagner S, Morales K, Roach E. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May;103(10):3689-3694.
134. Adams R, Pavlakis S, Roach E. Sickle cell disease and stroke: Primary prevention and transcranial Doppler. Ann Neurol. 2003 Nov;54(5):559-563.
135. Krejza J, Rudzinski W, Pawlak M, Tomaszewski M, Ichord R, Kwiatkowski J, Gor D, Melhem E. Angle-corrected imaging transcranial doppler sonography versus imaging and nonimaging transcranial doppler sonography in children with sickle cell disease. AJNR Am J Neuroradiol. 2007 Sep;28(8):1613-1618.
136. Adams R. TCD in sickle cell disease. J Pediatr Hematol Oncol. 1996 Aug;18(3):331-334.
137. Clinical alert: Periodic transfusions lower stroke risk in children with sickle cell anemia. [Internet] National Heart, Lung, and Blood Institute. 1997. Last update: 09 October 1997. [cited 2010 Aug 3]; Available from: Http://www.nlm. nih.gov/databases/alerts/sickle97.html.
138. Lee M, Piomelli S, Granger S, Miller S, Harkness S, Brambilla D, Adams R. Stroke Prevention Trial in Sickle Cell Anemia (STOP): Extended follow-up and final results. Blood. 2006 Aug;108(3):847-852.
139. Bulas D. Screening children for sickle cell vasculopathy: Guidelines for transcranial Doppler evaluation. Pediatr Radiol. 2005 Mar;35(3):235-241. (Pubitemid 40425046)
140. Russell M, Goldberg H, Hodson A, Kim H, Halus J, Reivich M, Schwartz E. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood. 1984 Jan;63(1):162-169.
141. Pegelow C, Adams R, McKie V, Abboud M, Berman B, Miller S, Olivieri N, Vichinsky E, Wang W, Brambilla D. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun;126(6):896-899.
142. Wilimas J, Goff J, Anderson HJ, Langston J, Thompson E. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr. 1980 Feb;96(2):205-208.
143. Ausavarungnirun P, Sabio H, Kim J, Tegeler C. Dynamic vascular analysis shows a hyperemic flow pattern in sickle cell disease. J Neuroimaging. 2006 OCT;16(4):311-317.
144. Fullerton H, Adams R, Zhao S, Johnston S. Declining stroke rates in Californian children with sickle cell disease. Blood. 2004 Jul;104(2):336-339.
145. Enninful-Eghan H, Moore RH, Ichord R, Smith-Whitley K, Kwiatkowski JL. Transcranial Doppler Ultrasonography and Prophylactic Transfusion Program Is Effective in Preventing Overt Stroke in Children with Sickle Cell Disease. J Pediatr. 2010 Apr 29.
146. Silent Cerebral Infarct Multi-Center Clinical Trial. [Internet] ClinicalTrials.gov. 2003. Last Updated: May 6, 2010. [cited 2010 Aug 3]; Available from: Http://www.clinicaltrials. gov/ct/show/NCT00072761.
147. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH). [Internet] ClinicalTrials.gov. 2005. Last Updated: June 25, 2010. [cited 2010 Aug 3]; Available from: Http:// www.clinicaltrials.gov/ct/show/NCT00122980.
148. Krejza J, Kochanowicz J, Mariak Z, Lewko J, Melhem E. Middle cerebral artery spasm after subarachnoid hemorrhage: Detection with transcranial color-coded duplex US. Radiology. 2005 Aug;236(2):621-629.
149. Krejza J, Mariak Z, Lewko J. Standardization of flow velocities with respect to age and sex improves the accuracy of transcranial color Doppler sonography of middle cerebral artery spasm. AJR Am J Roentgenol. 2003 Jul;181(1):245-252.
150. Swiat M, Weigele J, Hurst RW, Kasner SE, Pawlak M, Arkuszewski M, Al-Okaili RN, Swiercz M, Ustymowicz A, Opala G, Melhem ER, Krejza J. Middle cerebral artery vasospasm: Transcranial color-coded duplex sonography versus conventional nonimaging transcranial Doppler sonography. Crit Care Med. 2009 Mar;37(3):963-968.
151. Krejza J, Baumgartner R. Clinical applications of transcranial color-coded duplex sonography. J Neuroimaging. 2004 Jul;14(3):215-225.
152. Jones A, Seibert J, Nichols F, Kinder D, Cox K, Luden J, Carl E, Brambilla D, Saccente S, Adams R. Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia. Pediatr Radiol. 2001 Jul;31(7):461-469.
153. Malouf AJ, Hamrick-Turner J, Doherty M, Dhillon G, Iyer R, Smith M. Implementation of the STOP protocol for Stroke Prevention in Sickle Cell Anemia by using duplex power Doppler imaging. Radiology. 2001 May;219(2):359-365.
154. McCarville M, Li C, Xiong X, Wang W. Comparison of transcranial Doppler sonography with and without imaging in the evaluation of children with sickle cell anemia. AJR Am J Roentgenol. 2004 Oct;183(4):1117-1122.
155. Riebel T, Kebelmann-Betzing C, Goetze R, Overberg U. Transcranial Doppler ultrasonography in neurologically asymptomatic children and young adults with sickle cell disease. Eur Radiol. 2003 Mar;13(3):563-570.
156. Lowe L, Bulas D. Transcranial Doppler imaging in children: Sickle cell screening and beyond. Pediatr Radiol. 2005 Jan;35(1):54-65.
157. Pawlak MA, Krejza J, Rudzinski W, Kwiatkowski JL, Ichord R, Jawad AF, Tomaszewski M, Melhem ER. Sickle cell disease: Ratio of blood flow velocity of intracranial to extracranial cerebral arteries-initial experience. Radiology. 2009 May;251(2):525-534.
158. Krejza J, Chen R, Romanowicz G, Kwiatkowski JL, Ichord R, Arkuszewski M, Zimmerman R, Ohene- Frempong K, Desiderio L, Melhem ER. Sickle cell disease and TCD imaging: Inter-hemispheric differences in blood flow Doppler parameters. Stroke. 2010. DOI: 10.1161/ STROKEAHA.110.591818.
159. Abboud M, Cure J, Granger S, Gallagher D, Hsu L, Wang W, Woods G, Berman B, Brambilla D, Pegelow C, Lewin J, Zimmermann R, Adams R. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood. 2004 Apr;103(7):2822-2826.
160. Wang W, Gallagher D, Pegelow C, Wright E, Vichinsky E, Abboud M, Moser F, Adams R. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000 Jul-Aug;22(4):335-339.
161. Wiznitzer M, Ruggieri P, Masaryk T, Ross J, Modic M, Berman B. Diagnosis of cerebrovascular disease in sickle cell anemia by magnetic resonance angiography. J Pediatr. 1990 Oct;117(4):551-555.
162. Ganesan V, Prengler M, Wade A, Kirkham F. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation. 2006 Nov;114(20):2170-2177.
163. Woodard P, Helton K, Khan R, Hale G, Phipps S, Wang W, Handgretinger R, Cunningham J. Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. Br J Haematol. 2005 May;129(4):550-552.
164. Kirkham F, DeBaun M. Stroke in Children with Sickle Cell Disease. Curr Treat Options Neurol. 2004 Sep;6(5):357-375.
165. Fryer R, Anderson R, Chiriboga C, Feldstein N. Sickle cell anemia with moyamoya disease: Outcomes after EDAS procedure. Pediatr Neurol. 2003 Aug;29(2):124-130.
166. Walters M, Storb R, Patience M, Leisenring W, Taylor T, Sanders J, Buchanan G, Rogers Z, Dinndorf P, Davies S, Roberts I, Dickerhoff R, Yeager A, Hsu L, Kurtzberg J, Ohene-Frempong K, Bunin N, Bernaudin F, Wong W, Scott J, Margolis D, Vichinsky E, Wall D, Wayne A, Pegelow C, Redding-Lallinger R, Wiley J, Klemperer M, Mentzer W, Smith F, Sullivan K. Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood. 2000 Mar;95(6):1918-1924.
167. Steen R, Helton K, Horwitz E, Benaim E, Thompson S, Bowman L, Krance R, Wang W, Cunningham J. Improved cerebrovascular patency following therapy in patients with sickle cell disease: Initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts. Ann Neurol. 2001 Feb;49(2):222-229.
168. Adams R, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005 Dec;353(26):2769-2778.
169. Minniti C, Gidvani V, Bulas D, Brown W, Vezina G, Driscoll M. Transcranial Doppler changes in children with sickle cell disease on transfusion therapy. J Pediatr Hematol Oncol. 2004 Oct;26(10):626-630.
170. Mazumdar M, Heeney M, Sox C, Lieu T. Preventing stroke among children with sickle cell anemia: An analysis of strategies that involve transcranial Doppler testing and chronic transfusion. Pediatrics. 2007 Oct;120(4):e1107-1116.
171. Krejza J, Swiat M, Tomaszewski M, Melhem E. Evidence-Based Imaging in Pediatrics. New York: Springer Science+Buisness Media; 2009. Chapter, Sickle Cell Disease and Stroke; p. 5-16. www.clinicaltrials.gov/ct/show/NCT00122980.
172. Wardlaw JM, Keir SL, Seymour J, Lewis S, Sandercock PA, Dennis MS, Cairns J. What is the best imaging strategy for acute stroke? Health Technol Assess. 2004 Jan;8(1):iii, ix-x, 1-180.
173. Adams HP, Jr., del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007 May;38(5):1655-1711.
174. Singer OC, Sitzer M, du Mesnil de Rochemont R, Neumann-Haefelin T. Practical limitations of acute stroke MRI due to patient-related problems. Neurology. 2004 May 25;62(10):1848-1849.
175. Lysakowski C, Walder B, Costanza MC, Tramer MR. Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: A systematic review. Stroke. 2001 Oct;32(10):2292-2298.
176. Wardlaw JM, White PM. The detection and management of unruptured intracranial aneurysms. Brain. 2000 Feb;123 ( Pt 2)(205-221.
177. Chappell ET, Moure FC, Good MC. Comparison of computed tomographic angiography with digital subtraction angiography in the diagnosis of cerebral aneurysms: A metaanalysis. Neurosurgery. 2003 Mar;52(3):624-631; discussion 630-621.
178. Willinsky RA, Taylor SM, TerBrugge K, Farb RI, Tomlinson G, Montanera W. Neurologic complications of cerebral angiography: Prospective analysis of 2,899 procedures and review of the literature. Radiology. 2003 May;227(2):522-528.
179. Burger IM, Murphy KJ, Jordan LC, Tamargo RJ, Gailloud P. Safety of cerebral digital subtraction angiography in children: Complication rate analysis in 241 consecutive diagnostic angiograms. Stroke. 2006 Oct;37(10):2535-2539.